Moderna
MRNA
#1163
Rank
S$25.66 B
Marketcap
S$64.72
Share price
-4.01%
Change (1 day)
79.67%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2025 : S$15.74 Billion

According to Moderna 's latest financial reports the company's total assets are S$15.74 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2025-12-31S$15.84 B-17.59%
2024-12-31S$19.22 B-21.01%
2023-12-31S$24.33 B-29.8%
2022-12-31S$34.66 B3.94%
2021-12-31S$33.35 B243.59%
2020-12-31S$9.70 B352.97%
2019-12-31S$2.14 B-20.06%
2018-12-31S$2.68 B84.8%
2017-12-31S$1.45 B-29.28%
2016-12-31S$2.05 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$254.15 B 1,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$141.54 B 799.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$174.61 B 1,009.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$95.46 M-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$9.47 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$6.33 B-59.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$2.04 B-87.00%๐Ÿ‡บ๐Ÿ‡ธ USA